Related Experiment Video
Updated: Jun 10, 2026

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
Thrombolytic therapy for cerebral embolism
1Department of Surgical Neuroangiography, Neurosurgery, Nakamura Memorial Hospital; Sapporo, Japan.
Insights
Thrombolytic therapy shows promise for cerebral embolism, particularly for middle cerebral artery (MCA) and basilar artery occlusions. Pre-treatment cerebral blood flow (CBF) measurement aids in assessing ischemia severity and preventing complications.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Radiology
Background:
- Cerebral embolism poses a significant risk for stroke.
- Thrombolytic therapy is a potential treatment, but its efficacy varies by occlusion site.
- Predicting treatment outcomes and complications is crucial.
Purpose of the Study:
- To evaluate the prognosis of thrombolytic therapy for cerebral embolism based on occlusion site.
- To assess the role of pre-treatment cerebral blood flow (CBF) measurement in supratentorial cerebral embolism.
- To compare thrombolytic therapy outcomes with conservative medical management.
Main Methods:
- Analysis of 56 cases of thrombolysis for cerebral embolism.
- Comparison of outcomes between thrombolysis and conservative medical therapy groups.
- Evaluation of pre-treatment CBF measurements for predicting outcomes and complications.
Main Results:
- Thrombolysis was discontinued for internal carotid artery (ICA) embolism due to poor collateral circulation.
- Middle cerebral artery (MCA) embolism showed significantly better outcomes with thrombolysis compared to conservative therapy.
- Basilar artery embolism demonstrated the highest effectiveness with thrombolysis, despite a high mortality rate.
- Pre-treatment CBF measurement proved useful in estimating ischemia severity and avoiding hemorrhagic complications.
Conclusions:
- Thrombolytic therapy is a viable option for specific cerebral embolism sites, notably MCA and basilar artery occlusions.
- Pre-treatment CBF measurement is critical for optimizing thrombolytic therapy and mitigating risks.
- Individualized treatment strategies based on occlusion site and CBF are essential for improving patient prognosis.
Summary:
We summarized our clinical experience of thrombolytic therapy for cerebral embolism to evaluate the relation between the prognosis and the occlusion site, and the role of pre-treatment CBF measurement for supratentorial cerebral embolism. 56 cases of thrombolysis were analyzed and results were compaired with conservative medical therapy group. For ICA embolism, we stopped thrombolysis in the early period because of its poor collateral circulation. MCA embolism seemed to be a good candidate for this treatment and results were significantly better than the conservative medical therapy group in good recovery rate, severe disablity rate and large size infarction rate. In basilar artery embolism, thrombolysis seemed to be the most effective treatment in spite of the high mortality rate. Pre-treatment CBF measurement was important and useful to estimate the severity of ischemia, and it could make it possible to avoid severe hemorrhagic complications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Ischemic Stroke ll: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Ischemic Stroke l: Introduction

